Caveolin-3 undergoes SUMOylation by the SUMO E3 ligase PIASy: sumoylation affects G-protein-coupled receptor desensitization.
Caveolin (Cav) proteins in the plasma membrane have numerous binding partners, but the determinants of these interactions are poorly understood. We show here that Cav-3 has a small ubiquitin-like modifier (SUMO) consensus motif (ΨKX(D/E, where Ψ is a hydrophobic residue)) near the scaffolding domain and that Cav-3 is SUMOylated in ... a manner that is enhanced by the SUMO E3 ligase PIASy (protein inhibitor of activated STAT-y). Site-directed mutagenesis revealed that the consensus site lysine is the preferred SUMOylation site but that mutation of all lysines is required to abolish SUMOylation. Co-expression of a SUMOylation-deficient mutant of Cav-3 with β-adrenergic receptors (βARs) alters the expression level of β(2)ARs but not β(1)ARs following agonist stimulation, thus implicating Cav-3 SUMOylation in the mechanisms for β(2)AR but not β(1)AR desensitization. Expression of endothelial nitric-oxide synthase (NOS3) was not altered by the SUMOylation-deficient mutant. Thus, SUMOylation is a covalent modification of caveolins that influence the regulation of certain signaling partners.
Mesh Terms:
Caveolin 3, Cell Line, Humans, Lysine, Protein Inhibitors of Activated STAT, Receptors, Adrenergic, beta-2, Receptors, G-Protein-Coupled, Small Ubiquitin-Related Modifier Proteins, Sumoylation, Ubiquitin-Protein Ligases
Caveolin 3, Cell Line, Humans, Lysine, Protein Inhibitors of Activated STAT, Receptors, Adrenergic, beta-2, Receptors, G-Protein-Coupled, Small Ubiquitin-Related Modifier Proteins, Sumoylation, Ubiquitin-Protein Ligases
J. Biol. Chem.
Date: Apr. 29, 2011
PubMed ID: 21362625
View in: Pubmed Google Scholar
Download Curated Data For This Publication
127893
Switch View:
- Interactions 2
- PTM Genes 1